Cargando…
P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642055/ http://dx.doi.org/10.1097/01.HS9.0000890808.16883.81 |
| _version_ | 1784826221227409408 |
|---|---|
| author | Fedorova, Liudmila Lepik, Kirill Mikhailova, Natalia Kondakova, Elena Komarova, Yaroslava Kotselyabina, Polina Borzenkova, Evgenia Baykov, Vadim Moiseev, Ivan Kulagin, Alexander |
| author_facet | Fedorova, Liudmila Lepik, Kirill Mikhailova, Natalia Kondakova, Elena Komarova, Yaroslava Kotselyabina, Polina Borzenkova, Evgenia Baykov, Vadim Moiseev, Ivan Kulagin, Alexander |
| author_sort | Fedorova, Liudmila |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9642055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96420552022-11-14 P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment Fedorova, Liudmila Lepik, Kirill Mikhailova, Natalia Kondakova, Elena Komarova, Yaroslava Kotselyabina, Polina Borzenkova, Evgenia Baykov, Vadim Moiseev, Ivan Kulagin, Alexander Hemasphere Immunotherapy Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9642055/ http://dx.doi.org/10.1097/01.HS9.0000890808.16883.81 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Immunotherapy Fedorova, Liudmila Lepik, Kirill Mikhailova, Natalia Kondakova, Elena Komarova, Yaroslava Kotselyabina, Polina Borzenkova, Evgenia Baykov, Vadim Moiseev, Ivan Kulagin, Alexander P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| title | P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| title_full | P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| title_fullStr | P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| title_full_unstemmed | P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| title_short | P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| title_sort | p060: prognosis of patients with relapsed and refractory classic hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment |
| topic | Immunotherapy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642055/ http://dx.doi.org/10.1097/01.HS9.0000890808.16883.81 |
| work_keys_str_mv | AT fedorovaliudmila p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT lepikkirill p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT mikhailovanatalia p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT kondakovaelena p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT komarovayaroslava p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT kotselyabinapolina p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT borzenkovaevgenia p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT baykovvadim p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT moiseevivan p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment AT kulaginalexander p060prognosisofpatientswithrelapsedandrefractoryclassichodgkinlymphomaafternivolumabdiscontinuationandefficacyofnivolumabretreatment |